Atlantia Clinical Trials

Atlantia Clinical Trials

Cork, Ireland· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Atlantia Clinical Trials is an Ireland-based CRO with 13 years of experience, providing comprehensive clinical research services across four key industries: Nutraceuticals, Medical Devices, Pharmaceuticals, and Cosmetics. The company operates owned clinic sites in Cork, Ireland and Chicago, USA, and has enrolled over 40,000 participants across 200+ completed trials. Atlantia's hybrid trial model blends onsite scientific rigor with remote flexibility, offering sponsors a 'best of both worlds' approach to accelerate product development and market entry with robust, compliant data.

Bone & Joint HealthCardiovascular HealthChronic PainCognitive HealthGut HealthImmune HealthMicrobiome HealthMetabolic HealthNutrition HealthSkin HealthStress & Low MoodWomen's Health

Technology Platform

Hybrid clinical trial service platform blending onsite scientific rigor at owned clinic sites with remote, decentralized trial capabilities for flexibility and cost-effectiveness. Supported by a Human Performance Lab and ISO 9001 certified quality management processes.

Opportunities

Growth is driven by increasing demand for scientific validation in the nutraceutical and functional food markets, expansion of hybrid/decentralized trial models, and the ongoing need for regulatory navigation in the US and EU.
Atlantia can deepen its vertical expertise, expand its geographic footprint, and form strategic partnerships with large ingredient or consumer health companies.

Risk Factors

Key risks include dependence on client R&D budgets, intense competition from both large global CROs and niche players, regulatory changes in the FDA or EFSA, and execution risks inherent in complex clinical trial management.
Economic downturns could reduce spending in its core verticals.

Competitive Landscape

Competes against large global CROs (e.g., IQVIA, Parexel) and specialized mid-sized CROs. Differentiation lies in its dedicated focus on nutraceuticals and cosmetics alongside pharma/devices, owned clinic infrastructure in the US and EU, hybrid trial model expertise, and deep dual-region (FDA/EFSA) regulatory knowledge.